CCL3 and Miyoshi myopathy: However, when analyzing MM patient-moDCs (n = 10), the expression of IL-12 (6.34 ± 5.51 vs. 8.27 ± 6.88 pg/ml, p = 0.458), TNF-α (4.42 ± 0.21 vs. 4.32 ± 0.32 pg/ml, p = 0.377) and MIP-1α (14.53 ± 2.76 vs. 13.76 ± 2.48 pg/ml, p = 0.248) from moDCs showed no significant difference between pomalidomide group and the control group (Figure 8).